RU2003138080A - Фармацевтическая композиция с антигиперлипидемической активностью - Google Patents

Фармацевтическая композиция с антигиперлипидемической активностью Download PDF

Info

Publication number
RU2003138080A
RU2003138080A RU2003138080/15A RU2003138080A RU2003138080A RU 2003138080 A RU2003138080 A RU 2003138080A RU 2003138080/15 A RU2003138080/15 A RU 2003138080/15A RU 2003138080 A RU2003138080 A RU 2003138080A RU 2003138080 A RU2003138080 A RU 2003138080A
Authority
RU
Russia
Prior art keywords
pharmaceutical composition
antihyperlipidemic activity
obesity
antihyperlipidemic
activity
Prior art date
Application number
RU2003138080/15A
Other languages
English (en)
Other versions
RU2292891C2 (ru
Inventor
Клаус МЮНТЕР (DE)
Клаус МЮНТЕР
Михаэль КИРХЕНГАСТ (DE)
Михаэль КИРХЕНГАСТ
Original Assignee
ЭББОТТ ГмбХ унд Ко. КГ (DE)
Эбботт Гмбх Унд Ко. Кг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ЭББОТТ ГмбХ унд Ко. КГ (DE), Эбботт Гмбх Унд Ко. Кг filed Critical ЭББОТТ ГмбХ унд Ко. КГ (DE)
Publication of RU2003138080A publication Critical patent/RU2003138080A/ru
Application granted granted Critical
Publication of RU2292891C2 publication Critical patent/RU2292891C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Claims (1)

  1. Фармацевтическая композиция с антигиперлипидемической активностью, содержащая активное вещество, отличающаяся тем, что в качестве активного вещества содержит соединение общей формулы (I)
    Figure 00000001
    где R означает метокси и R1 означает метил или метокси
    или
    R означает метил или группу
    Figure 00000002
    и R1 означает метил.
RU2003138080/15A 1997-12-05 2003-12-29 Фармацевтическая композиция с антигиперлипидемической активностью RU2292891C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19754082.1 1997-12-05
DE19754082A DE19754082A1 (de) 1997-12-05 1997-12-05 Methode zur Bekämpfung der Fettleibigkeit

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU2000117857/14A Division RU2000117857A (ru) 1997-12-05 1998-11-21 Способ борьбы с ожирением

Publications (2)

Publication Number Publication Date
RU2003138080A true RU2003138080A (ru) 2005-06-10
RU2292891C2 RU2292891C2 (ru) 2007-02-10

Family

ID=7850913

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2003138080/15A RU2292891C2 (ru) 1997-12-05 2003-12-29 Фармацевтическая композиция с антигиперлипидемической активностью

Country Status (17)

Country Link
US (1) US6197780B1 (ru)
EP (1) EP1035851B1 (ru)
JP (1) JP2002512173A (ru)
KR (1) KR20010032779A (ru)
CN (1) CN1152685C (ru)
AT (1) ATE204172T1 (ru)
AU (1) AU751053B2 (ru)
BR (1) BR9815335A (ru)
CA (1) CA2311423C (ru)
CZ (1) CZ300442B6 (ru)
DE (2) DE19754082A1 (ru)
ES (1) ES2162493T3 (ru)
HK (1) HK1037141A1 (ru)
HU (1) HUP0100171A3 (ru)
NO (2) NO324694B1 (ru)
RU (1) RU2292891C2 (ru)
WO (1) WO1999029308A2 (ru)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19533023B4 (de) * 1994-10-14 2007-05-16 Basf Ag Neue Carbonsäurederivate, ihre Herstellung und Verwendung
EP1130027A1 (de) * 2000-02-29 2001-09-05 Aventis Pharma Deutschland GmbH Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben
US20050175667A1 (en) * 2004-02-10 2005-08-11 Wenda Carlyle Use of endothelin antagonists to prevent restenosis
CA2904447C (en) 2007-08-22 2017-01-03 Abbvie Deutschland Gmbh & Co Kg Therapy for complications of diabetes
SI2776038T1 (en) * 2011-11-11 2018-06-29 Gilead Apollo, Llc ACC INHIBITORS AND THEIR USE
WO2016099233A2 (ru) * 2014-10-20 2016-06-23 Товарищество С Ограниченной Ответственностью "Фармацевтическая Компания "Ромат" Фармацевтическая композиция для лечения туберкулеза
AR106472A1 (es) 2015-10-26 2018-01-17 Gilead Apollo Llc Inhibidores de acc y usos de los mismos
HUE053175T2 (hu) 2015-11-25 2021-06-28 Gilead Apollo Llc ACC-gátló észterek és azok alkalmazása
CA3004747A1 (en) 2015-11-25 2017-06-01 Gilead Apollo, Llc Fungicidal compositions containing derivatives of 2,4-dioxo-1,4-dihydrothieno[2,3-d]pyrimidine
ES2939977T3 (es) 2015-11-25 2023-04-28 Gilead Apollo Llc Inhibidores de triazol ACC y usos de los mismos
EP3380480B1 (en) 2015-11-25 2022-12-14 Gilead Apollo, LLC Pyrazole acc inhibitors and uses thereof
CA3155220C (en) 2016-03-02 2024-01-16 Gilead Apollo, Llc Solid forms of a thienopyrimidinedione acc inhibitor and methods for production thereof
ES2927019T3 (es) 2017-03-28 2022-11-02 Gilead Sciences Inc Combinaciones terapéuticas para el tratamiento de enfermedades hepáticas

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0670320A4 (en) * 1992-12-01 1997-05-02 Green Cross Corp DERIVATIVE OF 1,8-NAPHTHYRIDIN-2-ONE AND USE OF THIS DERIVATIVE.
AU6603996A (en) * 1995-08-24 1997-03-19 Warner-Lambert Company Furanone endothelin antagonists
JP3116347B2 (ja) * 1996-11-13 2000-12-11 田辺製薬株式会社 医薬組成物

Also Published As

Publication number Publication date
NO20002777D0 (no) 2000-05-30
CN1152685C (zh) 2004-06-09
ES2162493T3 (es) 2001-12-16
CZ300442B6 (cs) 2009-05-20
EP1035851A2 (de) 2000-09-20
KR20010032779A (ko) 2001-04-25
EP1035851B1 (de) 2001-08-16
CN1301162A (zh) 2001-06-27
NO20074419L (no) 2000-06-02
CA2311423C (en) 2008-01-29
AU2153599A (en) 1999-06-28
HUP0100171A3 (en) 2003-10-28
BR9815335A (pt) 2000-10-17
DE59801230D1 (de) 2001-09-20
RU2292891C2 (ru) 2007-02-10
CA2311423A1 (en) 1999-06-17
JP2002512173A (ja) 2002-04-23
NO324694B1 (no) 2007-12-03
US6197780B1 (en) 2001-03-06
CZ20002006A3 (cs) 2000-11-15
DE19754082A1 (de) 1999-06-10
HUP0100171A2 (hu) 2003-02-28
ATE204172T1 (de) 2001-09-15
AU751053B2 (en) 2002-08-08
WO1999029308A2 (de) 1999-06-17
WO1999029308A3 (de) 1999-09-30
HK1037141A1 (en) 2002-02-01
NO20002777L (no) 2000-06-02

Similar Documents

Publication Publication Date Title
RU2214418C2 (ru) Аналоги glp-1
RU2003138080A (ru) Фармацевтическая композиция с антигиперлипидемической активностью
TR199901710T2 (xx) IL-8 resept�r antagonistleri.
ATE342922T1 (de) Immobilisierung von proteinen mit hilfe eines polypeptidsegments
EA200200261A1 (ru) Рецептор baff (bcma), иммунорегуляторный агент
DE3881668D1 (de) Piezoelektrische vibrator-pumpe.
RU94045826A (ru) Моноклональные антитела против рецептора интерферона, с нейтрализующим действием против интерферона типа i
EA199800733A1 (ru) Антагонисты рецептора il-8
RU97118224A (ru) Соединения и композиции для доставки активных агентов
EA200000311A1 (ru) Новый белок иммунной системы - кау
IT8847693A0 (it) Fenil carbammato farmacologicamente attivo, suo procedimento di preparazione e composizione farmaceutica che lo contiene
DE59601122D1 (de) N-(Benzofurazanyl)-Arylsulfonamide und ihre Analoge verwendbar als Endothelin-Rezeptor-Antagonisten
FI971404A (fi) Lääke nivelraumaan sisältäen IL-6-antagonistin aktiivisena aineena
BR9609653A (pt) Compostos e composições farmacêuticas contendo os mesmos
DE3774858D1 (de) Derivate von n-(2-alkyl-3-mercaptoglutaryl)-alpha-aminosaeuren und deren verwendung als collagenase-inhibitoren.
DE69728914D1 (de) Pharmazeutische Zusammensetzung gegen durch Papillomaviren verursachte Tumoren und Infektionen
BG96323A (bg) Нов полипептид и анти-нiv лекарство,получено от него
BR9800913A (pt) Promotor de gene cdc25b, preparação e uso do mesmo.
DE68924932D1 (de) Piezoelektrische Vibrator-Komponente.
TR199800521T1 (xx) Se�imli beta3 adrenerjik agonistler.
EE200100520A (et) N-(2-fenüül-4-aminobutüül)-1-naftamiidid neurokiniin-1-retseptori antagonistidena
EA200000198A1 (ru) 2-ациламинопропанамины в качестве антагонистов рецепторов тахикининов
ITTO960496A0 (it) Modificatione di farmaci polipeptidici per accrescere il flusso per e-lettrotrasporto.
BR9605046B1 (pt) compostos n-(pirimidinl)-benzenossulfonamida e preparação farmacêutica contendo as mesmas.
EA200000092A1 (ru) Противоаллергические средства

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20141122